{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:38:55Z","timestamp":1762868335695,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ctro.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T02:05:14Z","timestamp":1604887514000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database"],"prefix":"10.1016","volume":"26","author":[{"given":"James Robert","family":"Janopaul-Naylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas Subhash","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Asim","family":"Bilen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Carthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey Marie","family":"Hartsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashesh B.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2020.11.002_b0005","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020."},{"issue":"3","key":"10.1016\/j.ctro.2020.11.002_b0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients","volume":"19","author":"Stein","year":"2001","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.ctro.2020.11.002_b0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/COC.0000000000000471","article-title":"Comparison of outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder preservation","volume":"42","author":"Zhong","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2020.11.002_b0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.6004\/jnccn.2013.0116","article-title":"Trimodality bladder preservation therapy for muscle-invasive bladder cancer","volume":"11","author":"Chen","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.ctro.2020.11.002_b0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"issue":"34","key":"10.1016\/j.ctro.2020.11.002_b0030","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","article-title":"Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233","volume":"32","author":"Mak","year":"2014","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.ctro.2020.11.002_b0035","doi-asserted-by":"crossref","first-page":"78.e1","DOI":"10.1016\/j.urolonc.2017.10.013","article-title":"Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base","volume":"36","author":"Royce","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctro.2020.11.002_b0040","first-page":"38","article-title":"A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database","volume":"15","author":"Fischer-Valuck","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.002_b0045","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer Version 4.2020. 2020; National Comprehensive Cancer Network. Available at https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf."},{"issue":"3","key":"10.1016\/j.ctro.2020.11.002_b0050","first-page":"131","article-title":"The National Cancer Data Base: ten years of growth and commitment","volume":"48","author":"Partridge","year":"1998","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ctro.2020.11.002_b0055","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2016.03.050","article-title":"Radiosensitivity differences between liver metastases based on primary histology suggest impications for clinical outcomes after stereotactic body radiation therapy","volume":"95","author":"Ahmed","year":"2016","journal-title":"Int J Radiat Onc Phys"},{"issue":"8","key":"10.1016\/j.ctro.2020.11.002_b0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jtho.2018.04.027","article-title":"Radiosensitivity of lung metastases by primary histology and implications for stereotactic body radiation therapy using genomically adjusted radiation dose","volume":"13","author":"Ahmed","year":"2018","journal-title":"J Thorac Oncol."},{"issue":"9","key":"10.1016\/j.ctro.2020.11.002_b0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctro.2020.11.002_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00345-018-2421-5","article-title":"Update of the international consultation on urological disease on bladder cancer 2018: non-urothelial cancers of the urinary bladder","volume":"37","author":"Alanee","year":"2019","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.ctro.2020.11.002_b0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/iju.14206","article-title":"Adherence to guideline recommendations for multimodality treatment of patients with pT2\u20133 M0 non\u2010urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes","volume":"27","author":"Mistretta","year":"2020","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.ctro.2020.11.002_b0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1464-410X.2004.05034.x","article-title":"Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer","volume":"94","author":"Nieuwenhuijzen","year":"2004","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctro.2020.11.002_b0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.juro.2011.09.159","article-title":"Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer","volume":"187","author":"Eswara","year":"2012","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ctro.2020.11.002_b0090","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00345-019-02982-6","article-title":"Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases","volume":"38","author":"Gontero","year":"2020","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.ctro.2020.11.002_b0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00345-018-2411-7","article-title":"Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database","volume":"37","author":"Davaro","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.ctro.2020.11.002_b0100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.12688\/f1000research.16866.1","article-title":"Carrying out streamlined routine data analyses with reports for observational studies: introduction to a series of generic SAS\u00ae macros","volume":"7","author":"Liu","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.ctro.2020.11.002_b0105","doi-asserted-by":"crossref","unstructured":"Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215-34. Epub 2013\/08\/02. doi: 10.1515\/ijb-2012-0030. PubMed PMID: 23902694.","DOI":"10.1515\/ijb-2012-0030"},{"issue":"521","key":"10.1016\/j.ctro.2020.11.002_b0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing Covariates via Propensity Score Weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:07:58Z","timestamp":1762502878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630820300896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"alternative-id":["S2405630820300896"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.002","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}